Luiz Pereira de Magalhães et al. Marcio Jansen de Oliveira Figueiredo Fatima Dumas Cintra Eduardo Benchimol Saad … Ricardo Ryoshim Kuniyoshi Adalberto Menezes Lorga Filho Andre Luiz Buchele D'Avila Angelo Amato Vincenzo de Paola Carlos Antonio Abunader Kalil Dalmo Antonio Ribeiro Moreira Dario Celestino Sobral Filho Eduardo Back Sternick Francisco Carlos da Costa Darrieux Guilherme Fenelon Gustavo Glotz de Lima Jacob Atié José Carlos Pachón Mateos José Marcos Moreira José Tarcísio Medeiros de Vasconcelos Leandro Ioschpe Zimerman Luiz Roberto Leite da Silva Marcio Augusto Silva Mauricio Ibrahim Scanavacca Olga Ferreira de Souza
Introduction
Since 2009, when the Brazilian Society of Cardiology released the Brazilian Guidelines for Atrial Fibrillation, important studies on the subject have been published, particularly on new oral anticoagulants (NOACs). At least three of these drugs (dabigatran, rivaroxaban and apixaban) are currently approved for clinical use in Brazil.
In addition to pharmacological treatment, new data related to non-pharmacological treatment, notably the radiofrequency ablation (RA) procedure, have expanded the indication of this therapeutic approach. For this reason, an update of the guidelines is justified.
[…]